Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
30,970,782
-
Share change
-
-746,367
-
Total reported value
-
$52,650,184
-
Put/Call ratio
-
45%
-
Price per share
-
$1.70
-
Number of holders
-
35
-
Value change
-
-$1,127,765
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q2 2025
As of 30 Jun 2025,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,970,782 shares.
The largest 10 holders included
BVF INC/IL, TANG CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Opaleye Management Inc., Pfizer Inc, BANK OF AMERICA CORP /DE/, Aldebaran Capital, LLC, and DLD Asset Management, LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.